plerixafor has been researched along with Tauopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TF; Hsieh, ST; Kuo, MF; Lee, JE; Wang, KC; Wu, V; Yang, LY | 1 |
1 other study(ies) available for plerixafor and Tauopathies
| Article | Year |
|---|---|
Combination of indirect revascularization and endothelial progenitor cell transplantation improved cerebral perfusion and ameliorated tauopathy in a rat model of bilateral ICA ligation.
Topics: Animals; Brain Ischemia; Cerebrovascular Circulation; Chemokine CXCL12; Endothelial Progenitor Cells; Glycogen Synthase Kinase 3 beta; Neovascularization, Physiologic; Rats; Tauopathies | 2022 |